A detailed history of Reyes Financial Architecture, Inc. transactions in Exelixis, Inc. stock. As of the latest transaction made, Reyes Financial Architecture, Inc. holds 4,098 shares of EXEL stock, worth $160,436. This represents 0.11% of its overall portfolio holdings.

Number of Shares
4,098
Holding current value
$160,436
% of portfolio
0.11%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 01, 2025

BUY
$32.38 - $39.16 $132,693 - $160,477
4,098 New
4,098 $151 Million

Others Institutions Holding EXEL

About EXELIXIS, INC.


  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $12.6B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Reyes Financial Architecture, Inc. Portfolio

Follow Reyes Financial Architecture, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Reyes Financial Architecture, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Reyes Financial Architecture, Inc. with notifications on news.